Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COUP
Coupa Software Incorporated
COUP
|
+$628M |
| 2 |
Boston Scientific
BSX
|
+$399M |
| 3 |
Eli Lilly
LLY
|
+$366M |
| 4 |
Apple
AAPL
|
+$304M |
| 5 |
Shopify
SHOP
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$741M |
| 2 |
Meta Platforms (Facebook)
META
|
+$537M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$487M |
| 4 |
American Tower
AMT
|
+$449M |
| 5 |
Workday
WDAY
|
+$353M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Consumer Discretionary | 17.94% |
| 3 | Healthcare | 14.26% |
| 4 | Communication Services | 12.28% |
| 5 | Financials | 11.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
251
DELISTED
Sage Therapeutics
SAGE
| $31.1M | 0.03% |
431,209
-2,412,480
| -85% | -$297M |
|
252
Varonis Systems
VRNS
$4.58B
| $31.1M | 0.03% |
1,201,554
-19,968
| -2% | -$474K |
|
253
Glaukos
GKOS
$9.9B
| $30.5M | 0.03% |
560,144
+233,373
| +71% | +$14.2M |
|
254
Cardlytics
CDLX
$22.1M
| $30.3M | 0.03% |
48,229
-22,043
| -31% | -$10.8M |
|
|
BAND
255
Bandwidth Inc
BAND
$1.25B
| $30.3M | 0.03% |
472,912
+61,066
| +15% | +$3.54M |
|
256
Tandem Diabetes Care
TNDM
$1.3B
| $30.1M | 0.03% |
+504,605
| New | +$31.1M |
|
257
Cintas
CTAS
$82.7B
| $30M | 0.03% |
446,428
-265,748
| -37% | -$17.5M |
|
258
Lamb Weston
LW
$7.36B
| $29.3M | 0.03% |
340,358
-199,572
| -37% | -$16.1M |
|
259
Adecoagro
AGRO
$1.47B
| $29M | 0.03% |
3,466,046
-21,062
| -0.6% | -$141K |
|
260
Independence Realty Trust
IRT
$3.93B
| $28.9M | 0.03% |
2,056,086
-36,371
| -2% | -$530K |
|
261
Wells Fargo
WFC
$258B
| $28.9M | 0.03% |
537,998
-115,552
| -18% | -$6.05M |
|
262
Alcon
ALC
$33.9B
| $28.9M | 0.03% |
511,058
+262,079
| +105% | +$15M |
|
263
AXIS Capital
AXS
$7.67B
| $28.1M | 0.03% |
473,343
+215,759
| +84% | +$13.1M |
|
|
B
264
Barrick Mining
B
$63.2B
| $28.1M | 0.03% |
1,512,755
-1,154,976
| -43% | -$19.8M |
|
265
Sea Limited
SE
$65.1B
| $27.8M | 0.03% |
690,635
+43,169
| +7% | +$1.45M |
|
266
Agilent Technologies
A
$39.2B
| $27.8M | 0.03% |
+325,579
| New | +$25.6M |
|
267
First Bancorp
FBNC
$2.61B
| $27.3M | 0.03% |
683,982
-11,788
| -2% | -$451K |
|
|
INN
268
Summit Hotel Properties
INN
$748M
| $27.1M | 0.03% |
2,193,279
+326,068
| +17% | +$3.92M |
|
269
IMAX
IMAX
$2.61B
| $26.9M | 0.03% |
1,315,418
+12
| +0% | +$256 |
|
270
ING
ING
$99.8B
| $26.8M | 0.03% |
+2,226,183
| New | +$25.5M |
|
271
Ingersoll Rand
IR
$33B
| $26.7M | 0.03% |
727,382
-600,202
| -45% | -$19.7M |
|
272
Plains All American Pipeline
PAA
$17.5B
| $26.7M | 0.03% |
1,449,419
-16,491
| -1% | -$303K |
|
273
Neurocrine Biosciences
NBIX
$18.7B
| $26.6M | 0.03% |
247,528
+14,547
| +6% | +$1.52M |
|
274
Agios Pharmaceuticals
AGIO
$1.95B
| $26.2M | 0.03% |
548,353
+4,749
| +0.9% | +$179K |
|
275
ProQR Therapeutics
PRQR
$251M
| $26.1M | 0.03% |
2,630,626
+11,614
| +0.4% | +$90.5K |
|
Similar funds
Jennison Associates's Q4 2019 Portfolio in Review
As of Q4 2019, Jennison Associates held 706 positions worth $99.1B, up 4.7% from $94.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jennison Associates withdrew a net $6.18B in Q4 2019, closing 88 positions and reducing 342 holdings. Its most notable exit was Hexcel, an estimated $85.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in RingCentral worth $117M.
- Jennison Associates's largest Q4 2019 buy was RingCentral: 694,616 shares worth $117M.
- Jennison Associates added most to Coupa Software Incorporated in Q4 2019, an estimated $628M increase.
- Jennison Associates's biggest Q4 2019 reduction was Boeing, cutting an estimated $741M.
- Jennison Associates fully exited Hexcel in Q4 2019, selling an estimated $85.1M.
- Jennison Associates's ten largest holdings make up 34% of its $99.1B portfolio in Q4 2019.
- Jennison Associates opened 70 new positions and closed 88 in Q4 2019.
- Jennison Associates's portfolio value rose 4.7% quarter-over-quarter to $99.1B.
Based on Jennison Associates's 13F filing for Q4 2019, filed 7 Feb 2020.